Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-127256
Filing Date
2023-04-28
Accepted
2023-04-28 16:39:09
Documents
25

Document Format Files

Seq Description Document Type Size
1 DEF 14A d438976ddef14a.htm   iXBRL DEF 14A 790036
6 GRAPHIC g438976dsp61.jpg GRAPHIC 162976
7 GRAPHIC g438976dsp62.jpg GRAPHIC 159865
8 GRAPHIC g438976g00a44.jpg GRAPHIC 112205
9 GRAPHIC g438976g00a45.jpg GRAPHIC 95699
10 GRAPHIC g438976g00a46.jpg GRAPHIC 97755
11 GRAPHIC g438976g03d78.jpg GRAPHIC 48240
12 GRAPHIC g438976g11a11.jpg GRAPHIC 68807
13 GRAPHIC g438976g22a22.jpg GRAPHIC 75323
14 GRAPHIC g438976g26a01.jpg GRAPHIC 24519
15 GRAPHIC g438976g26b02.jpg GRAPHIC 28873
16 GRAPHIC g438976g26c03.jpg GRAPHIC 23038
  Complete submission text file 0001193125-23-127256.txt   4008853

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bbio-20221231.xsd EX-101.SCH 6279
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bbio-20221231_def.xml EX-101.DEF 6397
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bbio-20221231_lab.xml EX-101.LAB 10461
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bbio-20221231_pre.xml EX-101.PRE 6328
19 EXTRACTED XBRL INSTANCE DOCUMENT d438976ddef14a_htm.xml XML 377032
Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38959 | Film No.: 23867313
SIC: 2834 Pharmaceutical Preparations